Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesJun 11, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 11, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 11, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 11, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 11, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 11, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 11, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 11, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 11, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 11, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 11, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 5, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 23, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 7, 2007View HTMLDownload DOCDownload PDF
10-QQuarterly report which provides a continuing view of a company's financial positionMay 3, 2007View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesMay 2, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 2, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 2, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 2, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 2, 2007View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventMay 1, 2007View HTMLDownload DOCDownload PDFDownload XLS
DEF 14AOfficial notification to shareholders of matters to be brought to a vote ("Proxy")Apr 30, 2007View HTMLDownload DOCDownload PDFDownload XLS
SC 13GSchedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutionsApr 26, 2007View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventApr 23, 2007View HTMLDownload DOCDownload PDFDownload XLS
FWPFree Writing ProspectusApr 18, 2007View HTMLDownload DOCDownload PDFDownload XLS
1-25      26-50      51-75      76-98

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information